1. Home
  2. Labeler Index
  3. Ascent Pharmaceuticals, Inc
  4. 43602-552
  5. NDC Package Code: 43602-552-30 Lisdexamfetamine Dimesylate

NDC Package 43602-552-30 Lisdexamfetamine Dimesylate

Tablet, Chewable Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
43602-552-30
Package Description:
30 TABLET, CHEWABLE in 1 BOTTLE
Product Code:
43602-552
Proprietary Name:
Lisdexamfetamine Dimesylate
Non-Proprietary Name:
Lisdexamfetamine Dimesylate
Substance Name:
Lisdexamfetamine Dimesylate
Usage Information:
Lisdexamfetamine is used to treat attention deficit hyperactivity disorder (ADHD) as part of a total treatment plan, including psychological, social, and other treatments. It may help to increase the ability to pay attention, stay focused, and stop fidgeting. Lisdexamfetamine may also be used to treat binge eating disorder (BED). It may help to reduce the number of binge eating days. This medication is a stimulant. It is thought to work by restoring the balance of certain natural chemicals (neurotransmitters) in the brain. This medication is not recommended for use for weight loss due to the risk of serious side effects.
11-Digit NDC Billing Format:
43602055230
NDC to RxNorm Crosswalk:
  • RxCUI: 1871456 - lisdexamfetamine dimesylate 40 MG Chewable Tablet
  • RxCUI: 1871460 - lisdexamfetamine dimesylate 30 MG Chewable Tablet
  • RxCUI: 1871462 - lisdexamfetamine dimesylate 20 MG Chewable Tablet
  • RxCUI: 1871464 - lisdexamfetamine dimesylate 10 MG Chewable Tablet
  • RxCUI: 1871466 - lisdexamfetamine dimesylate 60 MG Chewable Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Ascent Pharmaceuticals, Inc
    Dosage Form:
    Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • LISDEXAMFETAMINE DIMESYLATE 20 mg/1
    • Pharmacologic Class(es):
  • Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)
  • Central Nervous System Stimulation - [PE] (Physiologic Effect)
    • DEA Schedule:
    Schedule II (CII) Substances
    Sample Package:
    No
    FDA Application Number:
    ANDA217068
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    08-25-2023
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    43602-552-05500 TABLET, CHEWABLE in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 43602-552-30?

    The NDC Packaged Code 43602-552-30 is assigned to a package of 30 tablet, chewable in 1 bottle of Lisdexamfetamine Dimesylate, a human prescription drug labeled by Ascent Pharmaceuticals, Inc. The product's dosage form is tablet, chewable and is administered via oral form.

    Is NDC 43602-552 included in the NDC Directory?

    Yes, Lisdexamfetamine Dimesylate with product code 43602-552 is active and included in the NDC Directory. The product was first marketed by Ascent Pharmaceuticals, Inc on August 25, 2023 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 43602-552-30?

    The 11-digit format is 43602055230. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-243602-552-305-4-243602-0552-30